A Phase I Trial Using RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer.
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2013
At a glance
- Drugs Everolimus (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions
- 01 Feb 2012 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Feb 2010 New trial record